5 septiembre 2014
Scientists have applied iPS technology to a model of Huntington’s disease in transgenic nonhuman primates, allowing them to conveniently assess the efficacy of potential therapies on neuronal cells in the laboratory.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/b5P_UuCSOjc/140905123108.htm
